Catasys Inc. (NASDAQ:CATS) has received an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.

Brokers have set a 12 month consensus price objective of $12.00 for the company, according to Zacks. Zacks has also given Catasys an industry rank of 73 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research upgraded shares of Catasys from a “sell” rating to a “hold” rating in a research report on Monday, August 7th.

Hedge funds have recently bought and sold shares of the business. Perkins Capital Management Inc. bought a new position in Catasys during the second quarter valued at $113,000. UBS Oconnor LLC bought a new position in Catasys during the second quarter valued at $834,000. Bard Associates Inc. bought a new position in Catasys during the second quarter valued at $1,012,000. Kennedy Capital Management Inc. bought a new position in Catasys during the second quarter valued at $1,385,000. Finally, FNY Partners Fund LP bought a new position in Catasys during the second quarter valued at $1,560,000. Institutional investors and hedge funds own 7.16% of the company’s stock.

Catasys (NASDAQ CATS) traded down 0.19% during trading on Friday, hitting $5.33. 54,585 shares of the stock were exchanged. The firm’s 50-day moving average is $4.72 and its 200 day moving average is $6.11. The firm’s market cap is $84.69 million. Catasys has a 52 week low of $3.56 and a 52 week high of $14.00.

Catasys (NASDAQ:CATS) last announced its quarterly earnings results on Tuesday, August 15th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.20) by $0.03. The company had revenue of $1.67 million for the quarter. Analysts expect that Catasys will post ($1.26) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/08/catasys-inc-cats-given-consensus-recommendation-of-strong-buy-by-brokerages.html.

About Catasys

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.